The
Wall Street Journal reported that Valeant Pharmaceuticals International Inc. (NYSE: VRX)
was exploring a possible acquisition of Zoetis Inc. (NYSE: ZTS). Shares of Valeant Pharmaceuticals plunged $4.38 to close at $228.83 while Zoetis stock plummeted $6.76 to close at $48.62.
Valeant rumored to be interested in Zoetis
June 26, 2015 at 17:39 PM EDT